Concomitant cisplatin and radiotherapy in a conventional and modified fractionation schedule in locally advanced head and neck cancer - A randomised phase II EORTC trial

By Bartelink H.   Van den Bogaert W.   Horiot J.-C.   Jager J.   van Glabbeke M.  

European Journal of Cancer, Vol. 38, Iss. 5, 2002-03 ,pp. : 667-673

Elsevier

Access to resources Recommend Favorite

Analysis of efficacy and toxicity of chemotherapy with cisplatin, 5-fluorouracil, methotrexate and leucovorin (PFML) and radiotherapy in the treatment of locally advanced squamous cell carcinoma of the head and neck

By Katori Hideaki   Tsukuda Mamoru   Taguchi Takahide  

Cancer Chemotherapy and Pharmacology, Vol. 59, Iss. 6, 2007-06 ,pp. : 789-794

Springer Publishing Company

Access to resources Recommend Favorite

Chemo-radiotherapy for Locally Advanced Head and Neck Cancer--Long-term Results of a Phase II Trial

By Dinges S.   Budach V.   Stuschke M.   Budach W.   Boehmer D.   Schrader M.   Jahnke K.   Sack H.  

European Journal of Cancer, Vol. 33, Iss. 7, 1997-06 ,pp. : 1152-1155

Elsevier

Access to resources Recommend Favorite

Role and extent of neck dissection for persistent nodal disease following chemo-radiotherapy for locally advanced head and neck cancer: How much is enough?

By Sandhu A.   Rao N.   Giri S.   He F.   Karakla D.   Wadsworth T.   McGaughey D.   Silverberg M.  

Acta Oncologica, Vol. 47, Iss. 5, 2008-05 ,pp. : 948-953

Informa Healthcare

Access to resources Recommend Favorite

Comparison of hyperfractionation and conventional fractionation radiotherapy with concurrent docetaxel, cisplatin and 5-fluorouracil (TPF) chemotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN)

By Katori Hideaki   Tsukuda Mamoru   Watai Kiichi  

Cancer Chemotherapy and Pharmacology, Vol. 60, Iss. 3, 2007-08 ,pp. : 399-406

Springer Publishing Company

Access to resources Recommend Favorite